Procter & Gamble Health Limited (NSE:PGHL)

Market Cap	109.51B +10.9%
Revenue (ttm)	14.08B +15.6%
Net Income	3.27B +30.1%
EPS	196.94 +30.3%
Shares Out	n/a
PE Ratio	33.50
Forward PE	29.35
Dividend	205.00 (3.09%)
Ex-Dividend Date	Aug 27, 2026

Volume	10,186
Open	6,500.00
Previous Close	6,502.00
Day's Range	6,460.00 - 6,714.00
52-Week Range	4,707.00 - 6,975.00
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble H...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Employees: 1,326
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PGHL

Financial Performance

In fiscal year 2026, Procter & Gamble Health's revenue was 14.08 billion, an increase of 15.59% compared to the previous year's 12.18 billion. Earnings were 3.27 billion, an increase of 30.14%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error